Table 2.
Comparison of baseline data between diabetes group and nondiabetes group.
| Nondiabetes group n = 22720 |
Diabetes group n = 1213 |
p | |
|---|---|---|---|
| Age | 47.09 ± 10.36 | 55.04 ± 8.76 | p ≤ 0.01 |
| Male sex | 12645 (55.7%) | 921 (75.9%) | p ≤ 0.01 |
| BMI | 23.99 ± 3.24 | 25.49 ± 3.06 | p ≤ 0.01 |
| WC | 83.68 ± 10.33 | 90.75 ± 9.08 | p ≤ 0.01 |
| SBP | 121.30 ± 16.54 | 128.80 ± 16.24 | p ≤ 0.01 |
| DBP | 72.58 ± 11.31 | 75.58 ± 10.16 | p ≤ 0.01 |
| FBG | 5.21 ± 0.85 | 7.94 ± 2.46 | p ≤ 0.01 |
| HBA1C | 5.39 ± 0.57 | 7.11 ± 1.33 | p ≤ 0.01 |
| TG | 1.68 ± 1.45 | 2.09 ± 1.91 | p ≤ 0.01 |
| TC | 4.81 ± 0.93 | 4.66 ± 1.06 | p ≤ 0.01 |
| HDL | 1.27 ± 0.32 | 1.16 ± 0.29 | p ≤ 0.01 |
| LDL | 2.69 ± 0.75 | 2.53 ± 0.81 | p ≤ 0.01 |
| ALT | 25.75 ± 22.99 | 29.04 ± 21.86 | p ≤ 0.01 |
| AST | 20.57 ± 11.43 | 20.98 ± 15.22 | 0.326 |
| UA | 350.97 ± 90.68 | 361.21 ± 84.65 | p ≤ 0.01 |
| BUN | 4.82 ± 1.16 | 5.34 ± 1.41 | p ≤ 0.01 |
| CR | 70.68 ± 16.00 | 72.02 ± 18.13 | 0.011 |
| FT3 | 2.90 ± 0.40 | 2.81 ± 0.36 | p ≤ 0.01 |
| FT4 | 1.01 ± 0.11 | 1.03 ± 0.12 | p ≤ 0.01 |
| TSH | 1.84 ± 1.48 | 1.71 ± 1.12 | p ≤ 0.01 |
| TGAB | 15.75 ± 71.73 | 10.56 ± 56.69 | p ≤ 0.01 |
| TPOAB | 17.94 ± 88.22 | 13.49 ± 78.19 | 0.055 |
Note: BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; FBG: fast blood glucose; HBA1C: glycated hemoglobin; TC: total cholesterol; TG: triglycerides; LDL: low-density lipoprotein; HDL: high-density lipoprotein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; UA: serum uric acid; BUN: blood urea nitrogen; CR: creatinine; FT3: free triiodothyronine; FT4: free thyroxine; TSH: thyroid-stimulating hormone; TGAB: thyroid peroxidase antibody; TPOAB: thyroglobulin antibody. p < 0.05 was considered statistically significant.